FDA.reportPublic FDA data

Drug Facts

Manufacturer
L’Oreal USA Products Inc | L'OREAL USA, INC.
Effective date
2026-05-18
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
weekly-update
Hydrated at
2026-07-17 21:41:56

Label at a glance#

ProductCeraVe Anti-Dandruff Hydrating Conditioner
Active ingredientPYRITHIONE ZINC
Label structure11 sections

Dosage and administration

for best results use at least twice a week or as directed by a doctor use after CeraVe Anti-Dandruff Shampoo rinse and repeat if desired

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Pyrithione zinc 0.51%

Purpose

OTC - PURPOSE SECTION

Antidandruff

Use

INDICATIONS & USAGE SECTION

helps prevent recurrence of scalp flaking and itching associated with dandruff

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

OTC - STOP USE SECTION

condition worsens or does not improve after regular use of this product as directed

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • for best results use at least twice a week or as directed by a doctor
  • use after CeraVe Anti-Dandruff Shampoo
  • rinse and repeat if desired

Inactive ingredients

INACTIVE INGREDIENT SECTION

water, cetearyl alcohol, behentrimonium chloride, glycerin, PEG-180, amodimethicone, cetyl esters, ceramide NP, ceramide AP, ceramide EOP, carbomer, zinc gluconate, niacinamide, trideceth-6, triethyl citrate, sodium lauroyl lactylate, sodium hyaluronate, sodium polynaphthalenesulfonate, sodium chloride, cholesterol, phenoxyethanol, chlorhexidine dihydrochloride, isopropyl alcohol, propylene glycol, hydroxyethylcellulose, cetrimonium chloride, caprylyl glycol, xanthan gum, phytosphingosine, benzoic acid

Questions or comments?

OTC - QUESTIONS SECTION

Toll-free number 1-888-768-2915

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

tubetube

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 30 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
82046-24382046-243-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 29 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
CETEARYL ALCOHOL2DMT128M1SIACT
BEHENTRIMONIUM CHLORIDEX7GNG3S47TIACT
GLYCERINPDC6A3C0OXIACT
PEG-180Q662QK8M3BIACT
AMODIMETHICONE (1300 CST)3V7U636DWNIACT
CETYL ESTERSD072FFP9GUIACT
CERAMIDE NP4370DF050BIACT
CERAMIDE APF1X8L2B00JIACT
CARBOMER0A5MM307FCIACT
ZINC GLUCONATEU6WSN5SQ1ZIACT
NIACINAMIDE25X51I8RD4IACT
TRIDECETH-63T5PCR2H0CIACT
TRIETHYL CITRATE8Z96QXD6UMIACT
SODIUM LAUROYL LACTYLATE7243K85WFOIACT
SODIUM HYALURONATEYSE9PPT4THIACT
SODIUM CHLORIDE451W47IQ8XIACT
CHOLESTEROL97C5T2UQ7JIACT
PHENOXYETHANOLHIE492ZZ3TIACT
CHLORHEXIDINE DIHYDROCHLORIDEE64XL9U38KIACT
ISOPROPYL ALCOHOLND2M416302IACT
PROPYLENE GLYCOL6DC9Q167V3IACT
HYDROXYETHYLCELLULOSET4V6TWG28DIACT
CETRIMONIUM CHLORIDEUC9PE95IBPIACT
CAPRYLYL GLYCOL00YIU5438UIACT
XANTHAN GUMTTV12P4NEEIACT
PHYTOSPHINGOSINEGIN46U9Q2QIACT
BENZOIC ACID8SKN0B0MIMIACT
PYRITHIONE ZINCR953O2RHZ5ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CeraVe Anti-Dandruff Hydrating ConditionerPYRITHIONE ZINCLOreal USA Products Inc521c263e-d29c-2564-e063-6394a90a2e1d2026-05-18WarningsExact identifier
ndc (package): 82046-243-01
ndc (product): 82046-243
ndc11 (package): 82046024301
spl id: 521c263e-d29d-2564-e063-6394a90a2e1d
spl set id: 521c263e-d29c-2564-e063-6394a90a2e1d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.